Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.
Clinical Trials: Yes.
NEWS & PARTNERSHIPS:
2017
The company signed an exclusive agreement with Dalton Pharma Services to supply pharmaceutical CBD in Canada. The company will use Dalton’s manufacturing services and expertise to provide pharmaceutical cannabidiol for the company’s research and development program being conducted at Faculty of Pharmaceutical Sciences at the University of Alberta.
2020
The company renewed its exclusive agreement with Dalton Pharma Services.
The company signed a supplier agreement with Medical Cannabis by Shoppers enabling them to be the exclusive retailer of Cardiol Rx CBD-products throughout Canada through its online platform.
Cortalex was exclusively introduced at Medical Cannabis by Shoppers online portal across Canada.
2024
CardiolRx was granted an Orphan Drug Designation by the FDA.
BRANDS:
CardiolRx is produced pharmaceutically, manufactured under cGMP, and is THC-free. Study results demonstrate that the API in CardiolRx inhibits and also promotes the reversal of mechanisms known to play a role in the occurrence and development of fibrotic CVD.